John D. Lewis, Ph.D.

Chief Executive Officer at Entos Pharmaceuticals

Speaker

Dr. John Lewis is a professor in Oncology and the Bird Dogs Chair in Translational Oncology at the University of Alberta, and the Founder and Chief Executive Officer of several biotech companies, including Entos Pharmaceuticals. As a scientist and an entrepreneur John Lewis translates scientific discoveries from the lab to the clinic to improve patient health and quality of life. Entos Pharmaceuticals is a clinical-stage biotechnology company developing next generation genetic medicines using its Fusogenix PLV nucleic acid delivery system. Dr. Lewis trained at The Scripps Research Institute and received a Ph.D. in Biochemistry from the University of Victoria.